Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Gestational diabetes increases risks for mothers and babies, needing early diagnosis and care.

The new Brigatinib nanocarrier is more effective against lung cancer cells than the free drug.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

Ginsenoside compound K shows promise for treating metabolic diseases like obesity and diabetes, but more research is needed on its safety and effectiveness.

Upadacitinib effectively treats severe alopecia areata and is safe.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

TAZ boosts fat cell formation in goat stem cells by activating a specific signaling pathway.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Nanocarriers with spironolactone and 2-deoxy-D-ribose may improve hair loss treatment by targeting hair follicles directly.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Baricitinib works better than methotrexate for severe alopecia areata.

Patients with alopecia areata using Janus kinase inhibitors are not following lab monitoring guidelines.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

Metformin may lower PSA levels, possibly affecting prostate cancer development.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Spironolactone and metformin work similarly for PCOS symptoms, but more research is needed.

A diabetic cat with another gland issue got better after treatment with cabergoline, no longer needing insulin.

Second-generation antipsychotics offer no significant benefit over first-generation ones for schizophrenia.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Patients with alopecia areata prefer treatments that regrow scalp hair quickly over how often they need to take the medication.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Many drugs can cause lipid metabolism issues, and labels need better warnings.

Simvastatin helps hair regrowth in autoimmune alopecia by directly affecting T cells.

Tofacitinib treatment for hair loss may worsen acne.

Insulin resistance is linked to higher hormone levels in women with PCOS.